Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.

Malhotra P, Haslett P, Sherry B, Shepp DH, Barber P, Abshier J, Roy U, Schmidtmayerova H.

Sci Rep. 2019 Apr 12;9(1):5963. doi: 10.1038/s41598-019-41588-1.

2.

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.

Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC 3rd, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr.

J Oncol Pract. 2019 Apr;15(4):e289-e299. doi: 10.1200/JOP.18.00638. Epub 2019 Mar 4.

PMID:
30830833
3.

The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral Drugs.

Gerlach SL, Chandra PK, Roy U, Gunasekera S, Göransson U, Wimley WC, Braun SE, Mondal D.

Medicines (Basel). 2019 Feb 28;6(1). pii: E33. doi: 10.3390/medicines6010033.

4.

Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.

Kim ES, Roy UB, Ersek JL, King J, Smith RA, Martin N, Martins R, Moore A, Silvestri GA, Jett J.

J Thorac Oncol. 2019 Mar;14(3):338-342. doi: 10.1016/j.jtho.2019.01.002. Epub 2019 Jan 30. No abstract available.

PMID:
30709747
5.

Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.

Roy U, Drozd V, Durygin A, Rodriguez J, Barber P, Atluri V, Liu X, Voss TG, Saxena S, Nair M.

Sci Rep. 2018 Jan 25;8(1):1603. doi: 10.1038/s41598-017-16703-9.

6.

Myeloid Zinc Finger 1 and GA Binding Protein Co-Operate with Sox2 in Regulating the Expression of Yes-Associated Protein 1 in Cancer Cells.

Verma NK, Gadi A, Maurizi G, Roy UB, Mansukhani A, Basilico C.

Stem Cells. 2017 Dec;35(12):2340-2350. doi: 10.1002/stem.2705. Epub 2017 Sep 29.

7.

Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers.

Kaushik A, Jayant RD, Nikkhah-Moshaie R, Bhardwaj V, Roy U, Huang Z, Ruiz A, Yndart A, Atluri V, El-Hage N, Khalili K, Nair M.

Sci Rep. 2016 May 4;6:25309. doi: 10.1038/srep25309.

8.

Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections.

Roy U, Barber P, Tse-Dinh YC, Batrakova EV, Mondal D, Nair M.

Front Microbiol. 2015 Sep 17;6:948. doi: 10.3389/fmicb.2015.00948. eCollection 2015. Review.

9.

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.

Roy U, Ding H, Pilakka-Kanthikeel S, Raymond AD, Atluri V, Yndart A, Kaftanovskaya EM, Batrakova E, Agudelo M, Nair M.

Int J Nanomedicine. 2015 Sep 18;10:5819-35. doi: 10.2147/IJN.S68348. eCollection 2015.

10.

The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials.

Roy U, Rodríguez J, Barber P, das Neves J, Sarmento B, Nair M.

Nanomedicine (Lond). 2015;10(24):3597-609. doi: 10.2217/nnm.15.160. Epub 2015 Sep 24. Review.

11.

DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine.

Roy U, Atluri VS, Agudelo M, Yndart A, Huang Z, Nair M.

Front Microbiol. 2015 Jul 28;6:749. doi: 10.3389/fmicb.2015.00749. eCollection 2015.

12.

Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.

Samikkannu T, Rao KV, Kanthikeel SP, Atluri VS, Agudelo M, Roy U, Nair MP.

Free Radic Biol Med. 2014 Apr;69:136-44. doi: 10.1016/j.freeradbiomed.2013.12.025. Epub 2014 Jan 27.

13.

Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir.

Roy U, Bulot C, Honer zu Bentrup K, Mondal D.

PLoS One. 2013 Oct 3;8(10):e75374. doi: 10.1371/journal.pone.0075374. eCollection 2013.

14.

Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV-1 infected monocytic cells.

Gerlach SL, Yeshak M, Göransson U, Roy U, Izadpanah R, Mondal D.

Biopolymers. 2013 Sep;100(5):471-9. doi: 10.1002/bip.22325.

PMID:
23897405
15.

Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.

Gautam N, Roy U, Balkundi S, Puligujja P, Guo D, Smith N, Liu XM, Lamberty B, Morsey B, Fox HS, McMillan J, Gendelman HE, Alnouti Y.

Antimicrob Agents Chemother. 2013 Jul;57(7):3110-20. doi: 10.1128/AAC.00267-13. Epub 2013 Apr 22.

16.

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY.

AIDS. 2012 Nov 13;26(17):2135-44. doi: 10.1097/QAD.0b013e328357f5ad.

17.

Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.

Roy U, McMillan J, Alnouti Y, Gautum N, Smith N, Balkundi S, Dash P, Gorantla S, Martinez-Skinner A, Meza J, Kanmogne G, Swindells S, Cohen SM, Mosley RL, Poluektova L, Gendelman HE.

J Infect Dis. 2012 Nov 15;206(10):1577-88. doi: 10.1093/infdis/jis395. Epub 2012 Jul 17.

18.

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.

Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE.

Int J Nanomedicine. 2012;7:2373-88. doi: 10.2147/IJN.S29454. Epub 2012 May 8.

19.

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.

Balkundi S, Nowacek AS, Veerubhotla RS, Chen H, Martinez-Skinner A, Roy U, Mosley RL, Kanmogne G, Liu X, Kabanov AV, Bronich T, McMillan J, Gendelman HE.

Int J Nanomedicine. 2011;6:3393-404. doi: 10.2147/IJN.S27830. Epub 2011 Dec 20.

20.

UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues.

Huang J, Gautam N, Bathena SP, Roy U, McMillan J, Gendelman HE, Alnouti Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2332-8. doi: 10.1016/j.jchromb.2011.06.032. Epub 2011 Jul 1.

Supplemental Content

Loading ...
Support Center